Alamar Biosciences: Qiming entities sell 173,673 shares

A $27.73 weighted-average price covered multiple executions, and the reported shares were held by four Qiming partnership entities.

Rhea-AI Filing Summary

Alamar Biosciences, Inc. (ALMR) common shares were sold indirectly by four Qiming holder entities: Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming Venture Partners VIII Investments, LLC, and Qiming Venture Partners VIII-HC, L.P. Sales totaled 173,673 shares on October 15 and 16, 2026. Prices included $27.02 and $28.26 per share, plus a $27.73 weighted-average price for multiple transactions at prices from $27.26 to $28.23. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 173,673 shares

Net Sell 12 txns

Insider Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P.

Role 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner

Sold 173,673 shs ($4.82M)

Type	Security	Shares	Price	Value
Sale	Common Stock F2	2	$27.02	$54.04
Sale	Common Stock F3	88	$27.02	$2K
Sale	Common Stock F4	21	$27.02	$567.42
Sale	Common Stock F5	25	$27.02	$675.50
Sale	Common Stock F1, F2	3,024	$27.73	$84K
Sale	Common Stock F2	9	$28.26	$254.34
Sale	Common Stock F1, F3	112,392	$27.73	$3.12M
Sale	Common Stock F3	325	$28.26	$9K
Sale	Common Stock F1, F4	26,224	$27.73	$727K
Sale	Common Stock F4	76	$28.26	$2K
Sale	Common Stock F1, F5	31,397	$27.73	$871K
Sale	Common Stock F5	90	$28.26	$3K

Holdings After Transaction: Common Stock — 1,890,817 shares (Indirect, See footnote)

Footnotes (5)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.23, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
2. F2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
3. F3. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
4. F4. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
5. F5. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

Key Figures

Shares sold: 173,673 shares Shares sold: 112,392 shares Sale price: $27.02 per share +3 more

6 metrics

Shares sold 173,673 shares Sales on October 15 and 16, 2026

Shares sold 112,392 shares Qiming Venture Partners VI, L.P.; October 15, 2026

Sale price $27.02 per share October 16, 2026

Weighted-average sale price $27.73 per share Certain October 15, 2026 sales; executions ranged from $27.26 to $28.23

Sale price $28.26 per share October 15, 2026

Execution price range $27.26 to $28.23 per share Multiple transactions underlying the weighted-average price

Key Terms

weighted average price, voting and dispositive power, beneficial ownership, general partner

4 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

voting and dispositive power regulatory

"may be deemed to have voting and dispositive power over the shares"

beneficial ownership regulatory

"disclaims beneficial ownership of such shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

general partner regulatory

"serves as the general partner"

A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALMR shares did Qiming-affiliated entities sell?

The four Qiming holder entities reported sales totaling 173,673 Alamar Biosciences shares on October 15 and 16, 2026. The transactions were indirect, and no Rule 10b5-1 plan is reported.

What were the reported ALMR sale prices?

Reported prices included $27.02 and $28.26 per share. For certain sales, $27.73 was a weighted-average price covering multiple transactions at prices from $27.26 to $28.23.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 04:30 PM EDT Accepted by SEC EDGAR 10/19/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qiming Corporate GP VI, Ltd.

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2026		S		3,024	D	$27.73(1)	182,139	I	See footnote(2)
Common Stock	10/15/2026		S		9	D	$28.26	182,130	I	See footnote(2)
Common Stock	10/15/2026		S		112,392	D	$27.73(1)	6,769,018	I	See footnote(3)
Common Stock	10/15/2026		S		325	D	$28.26	6,768,693	I	See footnote(3)
Common Stock	10/15/2026		S		26,224	D	$27.73(1)	1,579,421	I	See footnote(4)
Common Stock	10/15/2026		S		76	D	$28.26	1,579,345	I	See footnote(4)
Common Stock	10/15/2026		S		31,397	D	$27.73(1)	1,890,932	I	See footnote(5)
Common Stock	10/15/2026		S		90	D	$28.26	1,890,842	I	See footnote(5)
Common Stock	10/16/2026		S		2	D	$27.02	182,128	I	See footnote(2)
Common Stock	10/16/2026		S		88	D	$27.02	6,768,605	I	See footnote(3)
Common Stock	10/16/2026		S		21	D	$27.02	1,579,324	I	See footnote(4)
Common Stock	10/16/2026		S		25	D	$27.02	1,890,817	I	See footnote(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Qiming Corporate GP VI, Ltd.

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming Managing Directors Fund VI, L.P.

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VI, L.P.

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming GP VIII, LLC

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VIII Investments, LLC

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming GP VIII-HC, LLC

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Qiming Venture Partners VIII-HC, L.P.

(Last) (First) (Middle)

C/O MAPLES CORPORATE SERVICES LIMITED

PO BOX 309

(Street)

UGLAND HOUSE GRAND CAYMAN KY1-1104

(City) (State) (Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.23, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

3. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

4. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

5. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

	Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager	10/19/2026
	Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)